Increasing the Uptake of Influenza and Pneumococcal Vaccines Among High-Risk Adult Patients Through GP Clinics
1 other identifier
interventional
8,837
1 country
2
Brief Summary
Pneumonia and influenza are among the top causes of hospitalisation and death in the elderly. While vaccinations are recommended against these diseases, a large proportion of elderly in the community remain unvaccinated, with approximately only 10% vaccinated for either disease. In this study, the investigators aim to implement an intervention package within GP clinics to increase influenza and pneumococcal vaccination rates, especially among elderly patients with chronic diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2017
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 28, 2018
CompletedFirst Posted
Study publicly available on registry
February 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2018
CompletedJuly 5, 2019
June 1, 2019
9 months
January 28, 2018
July 1, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Difference in influenza vaccination uptake rate for clinics between intervention and non-intervention periods
The proportion of all eligible patients arriving at each clinic who receive influenza vaccine during the intervention period compared to the non-intervention period for each clinic.
8 months (post-study completion)
Difference in pneumococcal vaccination uptake rate for clinics between intervention and non-intervention periods
The proportion of all eligible patients arriving at each clinic who receive pneumococcal vaccine during the intervention period compared to the non-intervention period for each clinic.
8 months (post-study completion)
Study Arms (2)
Intervention
EXPERIMENTALClinics assigned to the intervention arm will receive an educational intervention. This comprises posters on vaccination to be put up in the clinic, as well as a flyer which will be handed out by the clinic assistants to all patients 65 years and above, at the point of registration. The poster and flyer content will provide simple messaging to encourage patients to receive influenza and pneumococcal vaccinations and inform them of available healthcare subsidies.
Control
NO INTERVENTIONClinics assigned to control arm will run as per their normal operations and not have the interventions implemented.
Interventions
a) The educational intervention comprises putting up posters on vaccination in the clinic, as well as provision of a specially designed flyer to the clinic, which will be handed out by the clinic assistants to all patients 65 years and above, at the point of registration. The poster and flyer content will provide simple messaging to encourage patients to receive influenza and pneumococcal vaccinations and inform them of available healthcare subsidies. b) Reminders to physicians: The flyers will also serve as physical prompts to physicians to encourage vaccination for their patients. Doctors and clinic staff will also be updated on the study protocol and the recommended adult vaccination schedule before commencement of the study.
Eligibility Criteria
You may qualify if:
- Patients seen at GP clinics involved in our study AND
- Aged 65 years and above, with or without chronic disease
You may not qualify if:
- Patients not seen at GP clinics involved in our study
- Patients aged below 65 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tan Tock Seng Hospitallead
- Frontier Healthcare Groupcollaborator
- OneCare Medical Groupcollaborator
Study Sites (2)
Frontier Healthcare Group
Singapore, 400305, Singapore
OneCare Medical Group
Singapore, 609966, Singapore
Related Publications (1)
Ho HJ, Tan YR, Cook AR, Koh G, Tham TY, Anwar E, Hui Chiang GS, Lwin MO, Chen MI. Increasing Influenza and Pneumococcal Vaccination Uptake in Seniors Using Point-of-Care Informational Interventions in Primary Care in Singapore: A Pragmatic, Cluster-Randomized Crossover Trial. Am J Public Health. 2019 Dec;109(12):1776-1783. doi: 10.2105/AJPH.2019.305328. Epub 2019 Oct 17.
PMID: 31622142DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dr Hanley Ho
Tan Tock Seng Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2018
First Posted
February 26, 2018
Study Start
November 1, 2017
Primary Completion
July 31, 2018
Study Completion
July 31, 2018
Last Updated
July 5, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share